Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 23, 2016Expert Opinion on PharmacotherapyOpen Access

Treatment options for infections caused by carbapenem-resistantEnterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?

View Full Paper
Ask AI
Bookmark
Share

Authors

FPFederico PérezGeriatric Research Education and Clinical CenterNCNadim G. El ChakhtouraKPKrisztina M. Papp‐WallaceNortheast Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pérez et al. (2016) studied this question.

synapsesocial.com/papers/6a7dccf877b363cb17b87682https://doi.org/10.1517/14656566.2016.1145658
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection2010 · 480 citations
  2. 2Carbapenem-ResistantEnterobacter cloacaeIsolates Producing KPC-3, North Dakota, USA2014 · 30 citations
  3. 3Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections2005 · 1,756 citations
  4. 4Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study2012 · 219 citations